Search research articles
Contact Us
Filters
Showing results (21-30 of 242) with videos related to
Page
of 25
Sort By:
Antimicrobial Agents and Chemotherapy
|
April 24, 2004
Bis-anthracycline antibiotics inhibit human immunodeficiency virus type 1 transcription
Olaf Kutsch, David N Levy, Paula J Bates, et al.
AIDS Research and Human Retroviruses
|
January 15, 2005
Complete genome analysis of one of the earliest SIVcpzPtt strains from Gabon (SIVcpzGAB2)
Frederic Bibollet-Ruche, Feng Gao, Elizabeth Bailes, et al.
Assay and Drug Development Technologies
|
May 5, 2007
High throughput drug screening for human immunodeficiency virus type 1 reactivating compounds
Jennifer Jones, John Rodgers, Marintha Heil, et al.
Retrovirology
|
August 15, 2013
Clonal amplification and maternal-infant transmission of nevirapine-resistant HIV-1 variants in breast milk following single-dose nevirapine prophylaxis
Sallie R Permar, Maria G Salazar, Feng Gao, et al.
Journal of Virology
|
August 13, 2011
Fitness costs and diversity of the cytotoxic T lymphocyte (CTL) response determine the rate of CTL escape during acute and chronic phases of HIV infection
Vitaly V Ganusov, Nilu Goonetilleke, Michael K P Liu, et al.
Retrovirology
|
June 4, 2011
Escape is a more common mechanism than avidity reduction for evasion of CD8+ T cell responses in primary human immunodeficiency virus type 1 infection
Emma L Turnbull, Joshua Baalwa, Karen E Conrod, et al.
The Journal of Infectious Diseases
|
September 12, 2013
Molecular mechanisms of HIV type 1 prophylaxis failure revealed by single-genome sequencing
Hui Li, Lily Blair, Yalu Chen, et al.
Journal of Virology
|
February 11, 2021
Immune Responses and Viral Persistence in Simian/Human Immunodeficiency Virus SHIV.C.CH848-Infected Rhesus Macaques
Widade Ziani, Anya Bauer, Hong Lu, et al.
Antimicrobial Agents and Chemotherapy
|
May 23, 2002
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy
Xiping Wei, Julie M Decker, Hongmei Liu, et al.
Journal of Virology
|
August 21, 2009
Broad neutralization of human immunodeficiency virus type 1 mediated by plasma antibodies against the gp41 membrane proximal external region
Elin S Gray, Maphuti C Madiga, Penny L Moore, et al.
Page
of 25
Search research articles
Search
Showing results (21-30 of 242) with videos related to
Sort By:
Page
of 25
Antimicrobial Agents and Chemotherapy
|
April 24, 2004
Bis-anthracycline antibiotics inhibit human immunodeficiency virus type 1 transcription
Olaf Kutsch, David N Levy, Paula J Bates, et al.
AIDS Research and Human Retroviruses
|
January 15, 2005
Complete genome analysis of one of the earliest SIVcpzPtt strains from Gabon (SIVcpzGAB2)
Frederic Bibollet-Ruche, Feng Gao, Elizabeth Bailes, et al.
Assay and Drug Development Technologies
|
May 5, 2007
High throughput drug screening for human immunodeficiency virus type 1 reactivating compounds
Jennifer Jones, John Rodgers, Marintha Heil, et al.
Retrovirology
|
August 15, 2013
Clonal amplification and maternal-infant transmission of nevirapine-resistant HIV-1 variants in breast milk following single-dose nevirapine prophylaxis
Sallie R Permar, Maria G Salazar, Feng Gao, et al.
Journal of Virology
|
August 13, 2011
Fitness costs and diversity of the cytotoxic T lymphocyte (CTL) response determine the rate of CTL escape during acute and chronic phases of HIV infection
Vitaly V Ganusov, Nilu Goonetilleke, Michael K P Liu, et al.
Retrovirology
|
June 4, 2011
Escape is a more common mechanism than avidity reduction for evasion of CD8+ T cell responses in primary human immunodeficiency virus type 1 infection
Emma L Turnbull, Joshua Baalwa, Karen E Conrod, et al.
The Journal of Infectious Diseases
|
September 12, 2013
Molecular mechanisms of HIV type 1 prophylaxis failure revealed by single-genome sequencing
Hui Li, Lily Blair, Yalu Chen, et al.
Journal of Virology
|
February 11, 2021
Immune Responses and Viral Persistence in Simian/Human Immunodeficiency Virus SHIV.C.CH848-Infected Rhesus Macaques
Widade Ziani, Anya Bauer, Hong Lu, et al.
Antimicrobial Agents and Chemotherapy
|
May 23, 2002
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy
Xiping Wei, Julie M Decker, Hongmei Liu, et al.
Journal of Virology
|
August 21, 2009
Broad neutralization of human immunodeficiency virus type 1 mediated by plasma antibodies against the gp41 membrane proximal external region
Elin S Gray, Maphuti C Madiga, Penny L Moore, et al.
Page
of 25